SARS-CoV-2 Vaccines in Kidney Transplant Recipients: Will They Be Safe and Effective and How Will We Know?

Heldman, Madeleine R; Limaye, Ajit P

Heldman, Madeleine R; Limaye, Ajit P.

Heldman MR; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington.
Limaye AP; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington limaye@uw.edu.

J Am Soc Nephrol ; 32(5): 1021-1024, 2021 05 03.

Article in English | MEDLINE | ID: covidwho-1150601

Subject(s)

COVID-19 Vaccines/pharmacology; COVID-19/prevention & control; Kidney Transplantation; COVID-19/immunology; COVID-19 Vaccines/adverse effects; COVID-19 Vaccines/immunology; Graft Rejection/etiology; Graft Rejection/immunology; Humans; Kidney Transplantation/adverse effects; Pandemics; SARS-CoV-2/immunology; Safety; Transplant Recipients; Transplantation Immunology; Treatment Outcome; Viral Load/immunology

Keywords

COVID-19; kidney transplantation; organ transplant; virology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Kidney Transplantation / COVID-19 Vaccines / COVID-19 Type of study: Experimental Studies / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: J Am Soc Nephrol Journal subject: Nephrology Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google